Mesothelioma Legal News

Immunotherapy Could Potentially be used Instead of Chemotherapy in Mesothelioma Patients

Asbestos is a dangerous mineral that causes many different cancers including mesothelioma, lung cancer, and colon cancer. In the case of mesothelioma, its sharp, microscopic fibers are first inhaled and then become embedded in the mesothelial tissue surrounding the lungs. Since asbestos is only regulated and not banned in the United States, people can still

more

Case Study Shows Asbestos in Talc Causes Mesothelioma

Prolonged exposure to asbestos-contaminated talcum powder has led to malignant mesothelioma cancer, according to an extensive case study by a leading occupational medicine and epidemiology organization. The study examined 33 mesothelioma patients, mostly women, whose only significant exposure to asbestos involved cosmetic talc. Researchers believe they found a definitive link. The Journal of Occupational and…

The post Case Study Shows Asbestos in Talc Causes Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Effective Second-Line Treatment for Mesothelioma Gaining Ground

Doctors at the Swiss Group for Clinical Cancer Research in Zurich, Switzerland, have uncovered a novel, anti-tumor compound that could become a needed second-line treatment for pleural mesothelioma cancer. Their recent multicenter phase II clinical trial conducted in Switzerland and Italy revealed the safety and efficacy of lurbinectedin, a synthetically produced agent that inhibits the…

The post Effective Second-Line Treatment for Mesothelioma Gaining Ground appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

First FDA Approved Mesothelioma Treatment in 15 Years to be Used Soon

A new cancer treatment using electricity has been approved for use in mesothelioma patients. The NovoTTF-100L uses Tumor Treating Fields, which are electric signals tuned to a specific frequency, to disrupt cancerous cell division. The fields are applied to the patient with adhesive bandages and are used for at least 18 hours a day. This

more

New York’s MTA Ignored Asbestos Dangers for Years

Glaring safety issues involving asbestos exposure within the Metropolitan Transportation Authority extend further than the East New York bus depot in Brooklyn, a report from the agency’s inspector general alleges. Inhaling or ingesting tiny asbestos fibers in the air can lead to serious health conditions later in life, including mesothelioma cancer. The inspector general report,…

The post New York’s MTA Ignored Asbestos Dangers for Years appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Keytruda for Mesothelioma Flops in Phase III Clinical Trial

Results from a phase III clinical trial comparing Keytruda (pembrolizumab) to standard chemotherapy shows the immunotherapy drug still has a long way to go as a viable treatment option for malignant pleural mesothelioma. Keytruda did not improve progression-free survival for mesothelioma patients who progressed after first-line chemotherapy. The disappointing results from the PROMISE-meso study were…

The post Keytruda for Mesothelioma Flops in Phase III Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Looking Back on Mesothelioma Awareness Day

Mesothelioma is a very rare and preventable cancer and because of this, many people do not know it exists or what causes it. Mesothelioma Awareness Day helps solve this by making people aware of the disease. Workers and families whose lives have been destroyed by the devastating effects of the disease can be celebrated and

more

First Mesothelioma Patient Begins Newly Approved Treatment

A mesothelioma patient at West Cancer Center in Memphis, Tennessee, is the first in the country to use NovoTTF-100L, a noninvasive electric therapy treatment, since its approval by the U.S. Food and Drug Administration in May. The FDA’s approval of Novocure’s Tumor Treating Fields device for the treatment of mesothelioma marked the first new FDA-approved…

The post First Mesothelioma Patient Begins Newly Approved Treatment appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma trial suggests immunotherapy as an alternative to chemotherapy

Patients with mesothelioma may gain similar benefit from immunotherapy as chemotherapy, and good responders may provide important clues to novel treatment for the thousands of new cases each year. New data highlight the need to understand the biologica…

CAR T-Cell Therapy Could Soon be used on Mesothelioma Patients

An immunotherapy treatment that utilizes T cells to fight cancer may soon be covered by Medicare for mesothelioma patients. Immunotherapy is still an emerging set of cancer treatments that utilizes the patient’s own immune system to fight and kill cancer cells. The specific treatment that uses T cells is called chimeric antigen receptor (CAR) T-cell

more

Inspector General Report: Asbestos Exposure a Concern on Army Posts

Residents in privatized housing on nearly 50 Army installations cited concerns with issues such as lead paint and asbestos, the toxic building material linked to mesothelioma cancer, according to a recent report from the Department of the Army Inspector General. The report, which was made public earlier this month, includes surveys, document reviews and interviews…

The post Inspector General Report: Asbestos Exposure a Concern on Army Posts appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.